ZEVRA THERAPEUTICS, INC. Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Zevra Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • Zevra Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$23.8M, a 281% decline year-over-year.
  • Zevra Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$74.8M, a 114% decline year-over-year.
  • Zevra Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$49.6M, a 16.5% decline from 2022.
  • Zevra Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$42.6M, a 651% decline from 2021.
  • Zevra Therapeutics, Inc. annual Operating Income (Loss) for 2021 was $7.73M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$49.6M -$7.04M -16.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 -$42.6M -$50.3M -651% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $7.73M +$13.3M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-07
2020 -$5.61M +$14.7M +72.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$20.3M +$35.6M +63.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 -$55.9M -$22.5M -67.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-28
2017 -$33.4M +$4.12M +11% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-01
2016 -$37.5M -$14.7M -64.3% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-30
2015 -$22.8M -$6.37M -38.7% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-30
2014 -$16.4M -$11.7M -249% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-10
2013 -$4.72M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.